Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VERACYTE, INC. Director's Dealing 2019

May 8, 2019

31551_dirs_2019-05-08_7153ce3c-d030-473f-93f7-d97d46c538da.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2019-05-06

Reporting Person: Hall Christopher M (President and COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-05-06 Common Stock M 42748 $8.86 Acquired 71462 Direct
2019-05-06 Common Stock M 63746 $6.45 Acquired 135208 Direct
2019-05-06 Common Stock M 8506 $5.98 Acquired 143714 Direct
2019-05-06 Common Stock S 28780 $24.72 Disposed 114934 Direct
2019-05-06 Common Stock S 86220 $25.4381 Disposed 28714 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-05-06 Stock Option (right to buy) $8.86 M 42748 Disposed 2025-03-01 Common Stock (42748.0) Direct
2019-05-06 Stock Option (right to buy) $6.45 M 63746 Disposed 2026-02-28 Common Stock (63746.0) Direct
2019-05-06 Stock Option (right to buy) $5.98 M 8506 Disposed 2028-03-01 Common Stock (8506.0) Direct

Footnotes

F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019.

F2: Represents weighted average sales price. Sale prices for the transactions range from $24.00 to $24.98. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F3: Represents weighted average sales price. Sale prices for the transactions range from $25.00 to $25.82. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F4: The option is fully vested.

F5: The option became exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

F6: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.